E-LIB Suche - Ergebnisse für: Craig I., Coleman

1

Comparison of Clinical Outcomes in Patients with Active Can..:

Cohen, Alexander T. ; Wallenhorst, Christopher ; Rivera, Marcella...
Thrombosis and Haemostasis. , 2024

2

Reply to "Letter to Dobesh et al. on lower mortality with a..:

Dobesh, Paul P. ; Fermann, Gregory J. ; Christoph, Mary J....
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 4 - p. 102429 , 2024

Link: https://doi.org/10.1016/..

3

Comparison of rivaroxaban and low molecular weight heparin ..:

Linder, Marie ; Ekbom, Anders ; Brobert, Gunnar...
Journal of Thrombosis and Thrombolysis. , 2024

Link: https://doi.org/10.1007/..

4

Agreement between 30-day and 90-day modified Rankin Scale s..:

Coleman, Craig I. ; Concha, Mauricio ; Baker, William L....
Journal of Clinical Neuroscience. 121 (2024) - p. 61-66 , 2024

Link: https://doi.org/10.1016/..

5

Using 30-day modified rankin scale score to predict 90-day ..:

Baker, William L. ; Sharma, Mukul ; Cohen, Alexander...
PLOS ONE. 19 (2024) 5 - p. e0303757 , 2024

Link: https://doi.org/10.1371/..

6

Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial..:

Kreutz, Reinhold ; Deray, Gilbert ; Floege, Jürgen...
JACC: Advances. 3 (2024) 2 - p. 100813 , 2024

Link: https://doi.org/10.1016/..

7

Andexanet alfa versus PCC products for factor Xa inhibitor ..:

White, C. Michael ; Caroti, Kimberly Snow ; Bessada, Youssef...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 44 (2024) 5 - p. 394-408 , 2024

Link: https://doi.org/10.1002/..

8

Effectiveness and Safety of Rivaroxaban and Low Molecular W..:

Coleman, Craig I. ; Caroti, Kimberly Snow ; Abdelgawwad, Khaled...
JACC: CardioOncology. 5 (2023) 2 - p. 189-200 , 2023

Link: https://doi.org/10.1016/..

9

Derivation and validation of a composite scoring system (SA..:

Coleman, Craig I. ; Concha, Mauricio ; Koch, Bruce...
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

Effectiveness and Safety of Rivaroxaban Versus Warfarin amo..:

Sood, Nitesh ; Ashton, Veronica ; Bessada, Youssef...
TH Open. 7 (2023) 1 - p. e82-e93 , 2023

Link: https://doi.org/10.1055/..

11

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad..:

Caroti, Kimberly Snow ; Khorana, Alok A. ; Becattini, Cecilia...
Clinical and Applied Thrombosis/Hemostasis. 29 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

12

Clinical and health care resource use burden of hospitaliza..:

Williams, James M. ; Lovelace, Belinda ; Christoph, Mary J....
Journal of the American College of Emergency Physicians Open. 4 (2023) 3 - p. , 2023

Link: https://doi.org/10.1002/..

13

Response to the Letter by Spurling and Colleagues:

Coleman, Craig I. ; Costa, Olivia S. ; Connolly, Stuart J....
Critical Care. 27 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

14

Lower mortality with andexanet alfa vs 4-factor prothrombin..:

Dobesh, Paul P. ; Fermann, Gregory J. ; Christoph, Mary J....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) 6 - p. 102192 , 2023

Link: https://doi.org/10.1016/..

15

Comparative outcomes associated with rivaroxaban versus war..:

Baker, William L. ; Roberts, Matthew S. ; Bessada, Youssef...
Current Medical Research and Opinion. 39 (2023) 9 - p. 1183-1194 , 2023

Link: https://doi.org/10.1080/..